1st Generation Antipsychotics Flashcards
First generation antipsychotics, general
D2 receptor antagonists
Dominated treatment from 1952 to 1990
Thorazine (chlorpromazine)
○ first AP drug, developed for allergies, then used as a sedative prior to surgery
• Healthcare providers noticed sx reduction in SZ patients prior to surgery
Mesolimbic DA pathway
Affiliated with reward-related cognitions
Large number of D2 receptors
Increased activation = positive symptoms of psychosis
It’s believed atypicals reduce mesolimbic dopamine
*tx effects generally require 1-3 weeks
Mesocortical DA Pathway
Affiliated with cognitive control
*high number of D1 and D4 receptors
Decreased activation = negative symptoms and cognitive deficits
*Antipsychotics do not reduce negative symptoms
[Typicals may actually increase negative symptoms]
Dopamine agonists such as stimulants like cocaine, actually reduce negative symptoms
Nigrostriatal DA Pathway
Involved with smooth motor movements
Destruction leads to Parkinsonism
Typicals decrease dopamine in the nigrostriatal, causing extrapyramidal symptoms (EPS)
Decreased fluidity and flow of motor movements
Tuberoinfundibular DA Pathway
Linked with the pituitary gland
Regulates sex drive
Blocking DA here yields changes in sex drive and alterations to secondary sex characteristics
*e.g. gynomastia
Extrapyramidal Symptoms (EPS)
Akathisia
Parkinsonism
Tardive dyskinesia
Dystonia
EPS: Akathisia
Motor restlessness or the inability to sit still
Considered by patients to be the least tolerable side effect
Responsible for suicidal behavior
EPS: Parkinsonism
Tremor
Bradykinesia (slow awkward movements)
Rigidity
Postural instability
EPS: Tardive dyskinesia
Characterized by repetitive, involuntary movements:
Grimacing; Tongue movements; Lip pursing, smacking, puckering; Excessive eye blinking
Rapid, involuntary movements of the limbs, torso, and fingers may also occur.
TD is often misdiagnosed as a mental illness
EPS Treatment
Adjunctive anticholinergic drug treatment
e.g
Cogentin, Artane, Benadryl
*Monitor anticholinergic SFX particularly if taken with other meds with anticholinergic activity (e.g. TCAs)
Decrease dosage of antipsychotic
*or try different AP (atypical, fewer EPS)
DA facilitators
e.g. L-Dopa
Beta-blockers
*e.g. propranolol – for akathisia
AP Potency
Based on “dopamine affinity”
How much is needed for a therapeutic effect
*i.e. dosage needed to block d2 receptors
High potency = higher EPS, lower anticholinergic sfx
e.g. Haldol 10mg
Low Potency= lower EPS, higher anticholinergix sfx
e.g. Thorazine 1000mg
Low Potency AP’s
e. g. Thorazine
e. g. Melorill
- Anticholinergic effects including sedation and confusion, but less EPS
- Start at low level–confusion, dizziness, hypotensive effect
HIgh Potency AP’s
e. g. Prolixin
e. g. Haldol
*More EPS, but less anticholinergic effects
Antipsychotics: indications
SZ
schizoaffective disorder
bipolar
- mood stabilization
- and/or when psychotic features are present
psychotic depression
delirium
dementia
trichotillomania
augmenting agent in treatment resistant anxiety disorders
EPS: Dystonia
Sustained or repetitive muscle contractions
Twisting and repetitive movements
Abnormal fixed postures